HeartBeam director receives 93,750-share stock grant

Q: What awards did HeartBeam (BEAT) director George de Urioste receive?

On October 2, 2026, director George de Urioste received 93,750 restricted stock units and a stock option covering 93,750 shares of common stock. Each restricted stock unit represents a contingent right to receive one common share upon settlement; the option's exercise price is $0.435 per share.

The awards follow separate vesting schedules, with continued service as a non-employee director required for vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HeartBeam, Inc. (BEAT) non-employee director George de Urioste received 93,750 restricted stock units and a stock option covering 93,750 common shares on October 2, 2026. The option has a $0.435 per-share exercise price and expires October 2, 2036. The RSUs vest in full on the earlier of October 2, 2027 or the date of the next annual meeting following the grant date, subject to continued service as a non-employee director. Half of the option shares vest on the grant date and the remaining half on January 1, 2027, subject to continued service through the applicable vesting dates; any then-unvested shares accelerate immediately prior to a Change in Control, as defined in the Plan.

Insider Trade Summary

Grant/Award: 187,500 shares

Grant/Award 2 txns

Insider de Urioste George

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units ^{F1, F2}	93,750	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) ^F3	93,750	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 93,750 contracts (Direct); Stock Option (Right to Buy) — 93,750 contracts (Direct)

Footnotes (3)

F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.
F2. The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
F3. The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).

Key Figures

Restricted stock units granted: 93,750 restricted stock units Option shares: 93,750 shares of common stock Option exercise price: $0.435 per share +3 more

6 metrics

Restricted stock units granted 93,750 restricted stock units Granted October 2, 2026

Option shares 93,750 shares of common stock Option granted October 2, 2026

Option exercise price $0.435 per share Stock option granted October 2, 2026

RSU vesting date Earlier of October 2, 2027 or the date of the next annual meeting of stockholders following the grant date Subject to continued service as a non-employee director

Option vesting schedule One-half on October 2, 2026; remaining one-half on January 1, 2027 Subject to continued service through the applicable vesting date

Option expiration date October 2, 2036 Stock option granted October 2, 2026

Key Terms

restricted stock unit (RSU), 2022 Equity Incentive Plan, Change in Control

3 terms

restricted stock unit (RSU) financial

"Each restricted stock unit ("RSU") represents a contingent right"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

2022 Equity Incentive Plan financial

"under the Issuer's 2022 Equity Incentive Plan, as amended"

Change in Control financial

"a Change in Control (as defined in the Plan)"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What awards did HeartBeam (BEAT) director George de Urioste receive?

On October 2, 2026, director George de Urioste received 93,750 restricted stock units and a stock option covering 93,750 shares of common stock. Each restricted stock unit represents a contingent right to receive one common share upon settlement; the option's exercise price is $0.435 per share.

When do HeartBeam (BEAT) director George de Urioste's awards vest?

The RSUs vest in full on the earlier of October 2, 2027 or the date of the next annual meeting of stockholders following the grant date, subject to continued service as a non-employee director. Half of the option shares vest on October 2, 2026, and the remaining half on January 1, 2027, subject to continued service; any then-unvested shares accelerate immediately prior to a Change in Control as defined in the Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/09/2026 - 04:21 PM EDT Accepted by SEC EDGAR 10/09/2026 - 04:21 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

de Urioste George

(Last)

(First)

(Middle)

2118 WALSH AVENUE, SUITE 210

(Street)

SANTA CLARA

CALIFORNIA

95050

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	10/02/2026		A		93,750		⁽²⁾	⁽²⁾	Common Stock	93,750	$0	93,750	D
Stock Option (Right to Buy)	$0.435	10/02/2026		A		93,750		⁽³⁾	10/02/2036	Common Stock	93,750	$0	93,750	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.

2. The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

3. The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).

	/s/ George de Urioste	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR